K. Wang
Lilly (China)(CN)
Publications by Year
Research Areas
Diabetes Management and Education, Chronic Disease Management Strategies, Tuberculosis Research and Epidemiology, Antimicrobial Resistance in Staphylococcus, Diabetes Treatment and Management
Most-Cited Works
- → Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment(2014)206 cited
- → Health‐related quality of life and marital quality of vitiligo patients in China(2010)99 cited
- → PDB71 ASSOCIATION OF SEVERE HYPOGLYCEMIA WITH ALL-CAUSE MORTALITY AND COMPLICATIONS AMONG PATIENTS WITH DIABETES MELLITUS IN CHINA(2019)1 cited
- → PDB110 THE UNMET MEDICAL NEEDS IN CURRENT ANTIDIABETIC INJECTABLE THERAPY (AIT) IN CHINA: FROM PATIENTS' PERSPECTIVE(2019)
- → PDG25 COST-EFFECTIVENESS OF ONCE WEEKLY DULAGLUTIDE 1.5 MG VERSUS ONCE DAILY LIRAGLUTIDE 1.8 MG FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) IN CHINA(2019)
- → PDB131 INSULIN TREATMENT PATTERN, RESOURCE UTILIZATION AND COSTS IN CHINESE PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED BASAL OR PREMIXED INSULIN ANALOGS AFTER INSULIN INTENSIFICATION(2019)
- → HEALTH CARE RESOURCE UTILIZATION AND DIRECT MEDICAL COST FOR INPATIENTS WITH OSTEOPOROTIC FRACTURE IN TIANJIN, CHINA(2016)
- → Resource Use and Outcomes of Patients Treated with Vancomycin or Linezolid in a Tertiary Hospital in Shanghai(2013)
- → PDB108 THE UNMET MEDICAL NEEDS IN CURRENT ANTIDIABETIC INJECTABLE THERAPY (AIT) IN CHINA: FROM THE PERSPECTIVE OF HEALTHCARE PROVIDERS (HCPS)(2019)
- → Clinical Outcomes and Hospital Costs Associated with Empirical Treatment of Hospital-Acquired Pneumonia with Vancomycin or Linezolid in a Chinese Tertiary Care Hospital: A Retrospective Cohort Study(2014)